Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Heise

Showing results (71-80 of 150) with videos related to

Pageof 15
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 27, 2026
Personal Viewpoint: Risk stratification and counseling of living kidney donor candidates with prediabetesKatafan Achkar, Fawaz Al Ammary, Muhammad Abdul-Ghani, et al.
Diabetes, Obesity & Metabolism|April 22, 2026
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Petrelintide for Weight Management: Two Randomized, Controlled Phase 1 TrialsMinna Brændholt Olsen, Jon Griffin, Ulrike Hövelmann, et al.
Diabetes Care|June 3, 2009
Biphasic insulin aspart 30/70: pharmacokinetics and pharmacodynamics compared with once-daily biphasic human insulin and Basal-bolus therapyTim Heise, Lutz Heinemann, Ulrike Hövelmann, et al.
Diabetes, Obesity & Metabolism|February 21, 2024
Pharmacokinetic and pharmacodynamic properties of once-weekly insulin icodec in individuals with type 1 diabetesUlrike Hövelmann, Susanne Engberg, Tim Heise, et al.
Metabolism: Clinical and Experimental|August 31, 2004
Effect of pramlintide on symptom, catecholamine, and glucagon responses to hypoglycemia in healthy subjectsTim Heise, Lutz Heinemann, Simon Heller, et al.
Diabetes Care|November 28, 2002
Absorption and metabolic effect of inhaled insulin: intrapatient variability after inhalation via the Aerodose insulin inhaler in patients with type 2 diabetesAyesh D Perera, Christoph Kapitza, Leszek Nosek, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 11, 2013
Safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple rising doses of empagliflozin in patients with type 2 diabetes mellitusTim Heise, Leo Seman, Sreeraj Macha, et al.
Plos One|August 31, 2013
The systemic immune network in recent onset type 1 diabetes: central role of interleukin-1 receptor antagonist (DIATOR Trial)Hubert Kolb, Kathrin Lückemeyer, Tim Heise, et al.
Clinical Drug Investigation|August 16, 2014
Glucose-lowering effect of insulin degludec is independent of subcutaneous injection regionLeszek Nosek, Hans-Veit Coester, Carsten Roepstorff, et al.
Metabolites|November 10, 2022
Association of HbA1c with VO<sub>2max</sub> in Individuals with Type 1 Diabetes: A Systematic Review and Meta-AnalysisMax L Eckstein, Felix Aberer, Florian J R Dobler, et al.
Pageof 15

Showing results (71-80 of 150) with videos related to

Sort By:
Pageof 15
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 27, 2026
Personal Viewpoint: Risk stratification and counseling of living kidney donor candidates with prediabetesKatafan Achkar, Fawaz Al Ammary, Muhammad Abdul-Ghani, et al.
Diabetes, Obesity & Metabolism|April 22, 2026
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Petrelintide for Weight Management: Two Randomized, Controlled Phase 1 TrialsMinna Brændholt Olsen, Jon Griffin, Ulrike Hövelmann, et al.
Diabetes Care|June 3, 2009
Biphasic insulin aspart 30/70: pharmacokinetics and pharmacodynamics compared with once-daily biphasic human insulin and Basal-bolus therapyTim Heise, Lutz Heinemann, Ulrike Hövelmann, et al.
Diabetes, Obesity & Metabolism|February 21, 2024
Pharmacokinetic and pharmacodynamic properties of once-weekly insulin icodec in individuals with type 1 diabetesUlrike Hövelmann, Susanne Engberg, Tim Heise, et al.
Metabolism: Clinical and Experimental|August 31, 2004
Effect of pramlintide on symptom, catecholamine, and glucagon responses to hypoglycemia in healthy subjectsTim Heise, Lutz Heinemann, Simon Heller, et al.
Diabetes Care|November 28, 2002
Absorption and metabolic effect of inhaled insulin: intrapatient variability after inhalation via the Aerodose insulin inhaler in patients with type 2 diabetesAyesh D Perera, Christoph Kapitza, Leszek Nosek, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 11, 2013
Safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple rising doses of empagliflozin in patients with type 2 diabetes mellitusTim Heise, Leo Seman, Sreeraj Macha, et al.
Plos One|August 31, 2013
The systemic immune network in recent onset type 1 diabetes: central role of interleukin-1 receptor antagonist (DIATOR Trial)Hubert Kolb, Kathrin Lückemeyer, Tim Heise, et al.
Clinical Drug Investigation|August 16, 2014
Glucose-lowering effect of insulin degludec is independent of subcutaneous injection regionLeszek Nosek, Hans-Veit Coester, Carsten Roepstorff, et al.
Metabolites|November 10, 2022
Association of HbA1c with VO<sub>2max</sub> in Individuals with Type 1 Diabetes: A Systematic Review and Meta-AnalysisMax L Eckstein, Felix Aberer, Florian J R Dobler, et al.
Pageof 15